Given that DNMT3A/B can serve as an oncogene and a tumor suppressor gene in the lung cancer [40], the new inhibitors with selectivity toward DNMT1 and DNMT3A/B should be particularly highlighted in the new drug design of DNMT inhibitors (DNMTi). This evidence concerns the gene DNMT1 and lung carcinoma.